REGULATORYRFK Jr.: 14 peptides returning to Category 1 — FDA advisory committee July 2026TRENDINGHexarelin: ↑↑ Surging ��� Trends score 100 as of May 2026UPDATESemaglutide and tirzepatide compounding ended — shortage resolved Feb/May 2025REGULATORYBPC-157, TB-500, thymosin alpha-1, CJC-1295, ipamorelin: expected Category 1 reclassification pendingEVENTpep-talk con ��� First US Peptide Convention · August 2026 · Anaheim CAFDAFDA advisory committee meetings scheduled: late July 2026REGULATORYRFK Jr.: 14 peptides returning to Category 1 — FDA advisory committee July 2026TRENDINGHexarelin: ↑↑ Surging ��� Trends score 100 as of May 2026UPDATESemaglutide and tirzepatide compounding ended — shortage resolved Feb/May 2025REGULATORYBPC-157, TB-500, thymosin alpha-1, CJC-1295, ipamorelin: expected Category 1 reclassification pendingEVENTpep-talk con ��� First US Peptide Convention · August 2026 · Anaheim CAFDAFDA advisory committee meetings scheduled: late July 2026

For research purposes only. Full disclaimer →

Results & Progress
5

Comparing GHK-Cu sources - purity matters

Parker Chen 15·4 days ago
After researching extensively and trying multiple approaches, I wanted to compile my findings here for others. The key takeaways are important for anyone considering this protocol.

Comments (4)

Sage Murphy 614·about 2 months ago

Thanks for sharing. I had a slightly different experience but your protocol is solid. One thing I would add is the importance of consistent timing.

2
Sage Johansson 714·about 1 month ago

Thanks for sharing. I had a slightly different experience but your protocol is solid. One thing I would add is the importance of consistent timing.

0
Sage Nakamura 814·20 days ago

Thanks for sharing. I had a slightly different experience but your protocol is solid. One thing I would add is the importance of consistent timing.

0
Sage Chen 14·4 days ago

Thanks for sharing. I had a slightly different experience but your protocol is solid. One thing I would add is the importance of consistent timing.

1

Sign in to comment.